Essential Planning LLC. Takes $2.26 Million Position in Encompass Health Co. (NYSE:EHC)

Essential Planning LLC. acquired a new position in Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 23,010 shares of the company's stock, valued at approximately $2,259,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. TD Private Client Wealth LLC raised its holdings in Encompass Health by 2,870.0% in the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company's stock valued at $709,000 after buying an additional 7,089 shares during the period. Pathstone Holdings LLC increased its position in shares of Encompass Health by 54.5% in the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock worth $2,032,000 after acquiring an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. raised its stake in shares of Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company's stock valued at $6,417,000 after acquiring an additional 20,242 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock valued at $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Finally, Central Pacific Bank Trust Division boosted its position in Encompass Health by 15.1% during the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company's stock worth $295,000 after purchasing an additional 418 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

A number of research analysts have commented on the company. Royal Bank of Canada restated an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. KeyCorp lifted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Finally, StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Stock Down 0.7 %

EHC traded down $0.71 during trading on Thursday, hitting $93.57. The company had a trading volume of 836,587 shares, compared to its average volume of 636,964. The company has a market cap of $9.42 billion, a PE ratio of 20.98, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 1-year low of $74.27 and a 1-year high of $104.55. The business has a 50-day moving average of $97.25 and a 200-day moving average of $96.86.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.73%. Encompass Health's payout ratio is 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.